Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes

Journal of General Virology

Volumn 79, Issue 2, 1998, Pages 353-361

  Mikloska, Zorka ^a   Cunningham, Anthony L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; VIRUS GLYCOPROTEIN;

ANTIGEN RECOGNITION; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELETION MUTANT; EPIDERMIS CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 0031985087     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-2-353     Document Type: Article

References (38)

1. Basham, T. Y., Nickoloff, B. J., Merigan, T. C. & Morhenn, V. B. (1984). Recombinant γ interferon induces HLA-DR expression on cultured human keratinocytes. Journal of Investigative Dermatology 83, 88-90.
2. Basham, T. Y., Nickoloff, B. J., Merigan, T. C. & Morhenn, V. B. (1985). Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured human keratinocytes. Journal of Interferon Research 5, 23-32.
3. Bastin, C., Hermand, P., Francotte, M., Garcon, N., Slaoui, M. & Pala, P. (1994). Synergistic association of adjuvants QS21 and MPL for induction of cytolytic T lymphocytes and T helper responses to recombinant protein antigens. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy of the American Society for Microbiology. Abstr. G41. Washington, DC: American Society for Microbiology.
4. Cantin, E. M., Eberle, R., Boldick, J. L., Moss, B., Willey, D. E., Notkins, A. R. & Openshaw, H. (1987). Expression of HSV glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal HSV-1 infection. Proceedings of National Academy of Sciences, USA 84, 5908-5912.
5. Cress, W. D. & Triezenberg, S. J. (1990). Critical structural elements of the VP16 transcriptional activation domain. Science 251, 87-90.
6. Cunningham, A. L. & Merigan, T. C. (1983). Gamma interferon production appears to predict time of recurrence of herpes labialis. Journal of Immunology 130, 2397-2400.
7. Cunningham, A. L. & Merigan, T. C. (1984). Leu3 T-cells produce gamma-interferon in patients with recurrent herpes labialis. Journal of Immunology 132, 197-202.
8. Cunningham, A. L. & Noble, J. R. (1989). Role of keratinocytes in human recurrent herpetic lesions. Journal of Clinical Investigation 83, 490-496.
9. Cunningham, A. L., Turner, R. R., Miller, A. C., Para, M. F. & Merigan, T. C. (1985). Evolution of recurrent herpes simplex lesions: an immunohistologic study. Journal of Clinical Investigation 75, 226-233.
10. Fauci, A. S. (1988). The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239, 617-622.
11. Fitzgerald-Bocarsly, P., Howell, D. M., Pettera, L., Tehrani, S. & Lopez, C. (1991). Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1 infected fibroblasts. Journal of Virology 65, 3151-3160.
12. Forrester, A. J., Sullivan, V., Simmons, A., Blacklaws, B. A., Smith, G. L., Nash, A. A. & Minson, A. C. (1991). Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. Journal of General Virology 72, 369-375.
13. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P. M., Tampe, R., Peterson, P. A. & Yang, Y. (1995). A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 415-418.
14. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. & Johnson, D. C. (1995). Herpes simplex virus turns off TAP to evade host immunity. Nature 375, 411-415.
15. Koelle, D. M., Tigges, M. A., Burke, R. L., Symington, F. W., Ridell, S. R., Abbo, H. & Corey, L. (1993). Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8 cytotoxic T-lymphocytes. Journal of Clinical Investigation 91, 961-968.
16. Koelle, D. M., Abbo, H., Peck, A., Ziegweid, K. & Corey, L. (1994a). Direct recovery of herpes simplex virus (HSV)-specific T-lymphocyte dones from recurrent genital HSV-2 lesions. Journal of Infectious Diseases 169, 956-961.
17. Koelle, D. M., Corey, L., Burke, R. L., Eisenberg, R. J., Cohen, G. H., Pichyangkura, R. & Triezenberg, S. J. (1994b). Antigenic specificities of human CD4 T cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. Journal of Virology 68, 2803-2810.
18. Lawman, J. R., Rouse, B. T., Courtney, R. J. & Walker, R. D. (1980). Cell-mediated immunity against herpes simplex virus: induction of cytotoxic T lymphocytes. Infection and Immunity 27, 133-139.
19. Martin, S., Courtney, R. J., Fowler, G. & Rouse, B. T. (1988). Herpes simplex virus type 1 specific cytotoxic T lymphocytes recognize viral nonstructural proteins. Journal of Virology 62, 2265-2273.
20. Martin, S., Mercadal, C. M., Weir, J. P. & Rouse, B. T. (1993). The proportion of herpes simplex virus specific cytotoxic T lymphocytes (Tc) that recognise glycoprotein C varies between individual mice and is dependent on the form of immunisation. Viral Immunology 6, 21-33.
21. Mikloska, Z., Kesson, A. M., Penfold, M. E. T. & Cunningham, A. L. (1996). Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-γ. Journal of Infectious Diseases 173, 7-17.
22. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68, 825-833.
23. Overall, J. C., Spruance, S. L. & Green, J. A. (1981). Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis. Journal of Infectious Diseases 143, 543-547.
24. Oxenius, A., Bachmann, M. F., Ashton-Rickardt, P. G., Tonegawa, S., Zinkernagel, R. M. & Hengartner, H. (1995). Presentation of endogenous viral proteins in association with major histocompatibility complex II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. European Journal of Immunology 25, 3402-3411.
25. Posavad, C. M. & Rosenthal, K. L. (1992). Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. Journal of Virology 66, 6204-6272.
26. Posavad, C. M., Newton, J. J. & Rosenthal, K. L. (1993). Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus. Journal of Immunology 151, 4865-4873.
27. Posavad, C. M., Koelle, D. M. & Corey, L. (1996). High frequency of CD8 cytotoxic T lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. Journal of Virology 70, 8165-8168.
28. Reeves, W. C., Corey, L., Adams, H. G., Vontver, L. A. & Holmes, K. K. (1981). Risk of recurrence after first episodes of genital herpes. New England Journal of Medicine 305, 315-319.
29. Schmid, D. S. & Rouse, B. T. (1992). The role of T cell immunity in control of herpes simplex virus. In Herpes Simplex Virus. Pathogenesis, Immunobiology and Control, pp. 57-74. Edited by B. T. Rouse. Berlin: Springer-Verlag.
30. Siegal, F. P., Lopez, C., Hammer, G. S., Brown, A. E., Kornfeld, S. J., Gold, J., Hassett, J., Hirschman, S. Z., Cunningham-Rundles, C. & Adelsberg, B. R. (1981). Severe acquired immunodefiecency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. New England Journal of Medicine 305, 1439-1444.
31. Spruance, S. L., Overall, J. C., Kern, E. R., Krueger, G. G., Pliam, V. & Miller, W. (1977). The natural history of recurrent herpes simplex labialis. New England Journal of Medicine 297, 69-75.
32. Stanberry, L. R. (1992). Pathogenesis of herpes simplex virus infection and animal models for its study. In Herpes Simplex Virus. Pathogenesis, Immunobiology and Control, pp. 15-30. Edited by B. T. Rouse. Berlin: Springer-Verlag.
33. Straus, S. E., Corey, L., Burke, R. L., Savarese, B., Barnum, G., Krause, P. R., Kost, R. G., Meier, J. L., Sekulovich, R., Adair, S. F. and others (1994). Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343, 1460-1463.
34. Torseth, J. W. & Merigan, T. C. (1986). Significance of local gamma interferon in recurrent herpes simplex infection. Journal of Infectious Diseases 153, 979-984.
35. Ward, P. L. & Roizman, B. (1994). Herpes simplex genes: the blueprint of a successful human pathogen. Trends in Genetics 10, 267-274.
36. Weinheimer, S. P., Boyd, B. A., Durham, S. K., Resnick, J. L. & O'Boyle, D. R. (1992). Deletion of VP16 open reading frame of herpes simplex virus type 1. Journal of Virology 66, 258-269.
37. York, I. A., Roop, C., Andrews, D. W., Riddell, S. R., Graham, F. L. & Johnson, D. C. (1994). A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 T-lymphocytes. Cell 77, 525-535.
38. Zarling, J. M., Moran, P. A., Burke, R. L., Pachl, C., Berman, P. W. & Lasky, L. A. (1986). Human cytotoxic T-cells directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. Journal of Immunology 136, 4669-4673.